Home › Mood Disorders › New York › New York City
Mood Disorders clinical trials in New York City, NY
4 studies for Mood Disorders are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RecruitingPhase 3
- Adams Clinical Harlem, New York
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
RecruitingPhase 2
- Seaport Investigator Site, New York
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- The Medical Research Network, LLC, New York
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
Recruiting
- Columbia University, New York
About Mood Disorders
Most people feel sad or irritable sometimes. They may say they're in a bad mood. But mood disorders affect your everyday emotional state. Learn more.
More about Mood Disorders on MedlinePlus
Mood Disorders trials in other cities
- Washington, DC6 studies
- Boston, MA5 studies
- Atlanta, GA4 studies
- Philadelphia, PA4 studies
- Columbus, OH3 studies
- Newton, MA3 studies
- Hollywood, FL3 studies
- Baltimore, MD3 studies
- Bellevue, WA3 studies
- Grand Prairie, TX3 studies
- Durham, NC3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.